Efficacy of nonablative radiofrequency on sexual function in postmenopausal women: a randomized clinical trial.
This single-blind randomized controlled trial evaluated nonablative capacitive-resistive monopolar radiofrequency versus sham in postmenopausal women with genitourinary syndrome of menopause. The intervention group reported significantly greater improvements in sexual function (FSFI) and vaginal health (VHI) at post-treatment and at 12-week follow-up. Vaginal cytology-based estrogenic status did not significantly change, and no adverse events were reported.
Key points
- Participants were randomized to six weekly sessions of monopolar radiofrequency (n=32) or sham treatment (n=30).
- Sexual function improved more in the radiofrequency group than in the sham group at post-treatment and 12-week follow-up.
- Vaginal health (VHI) improved more in the radiofrequency group than in the sham group at both time points.
- No significant changes were observed in vaginal cytology estrogenic status.
- No adverse events were reported in the study.
Referenced studies & papers
Relevant papers in OpenMel
Source:
Open original
AI-generated summaries may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.
AI-generated summaries may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.
Comments
Log in to comment.
No comments yet.